天涯社区

Tatsuro Ishibashi
President, 天涯社区

天涯社区 is proud to welcome President Tatsuro Ishibashi as the 24th President of 天涯社区. President Ishibashi’s six-year term leading the nearly 19,000 students and 2,000 faculty of 天涯社区 began on October 1.

“I am committed to working with our students, faculty, and staff to transform 天涯社区 into a world-leading university through autonomous reforms that bolster our efforts as a center for creative research and education,” said President Ishibashi.

A member of the 天涯社区 Graduate School of Medical Sciences’ class of 1981, President Ishibashi spent the last two and a half years as an executive vice president overseeing areas such as personnel, management of the hospital campuses, and harassment prevention at 天涯社区.

Prior to that, he had a prolific career in eye-related research with a focus on the retina at 天涯社区’s Department of Ophthalmology, where he began as a research assistant in 1981 and worked his way up to professor, a position that he held from 2001 to 2015.

During his time as a researcher, he spent two years abroad at the University of Southern California and the Doheny Eye Institute and has been an author on over 500 research papers. He also is part of a team of researchers who developed a dye for use in eye surgeries that became the first drug individually developed by Japanese universities to be approved by the Food and Drug Administration for use in the United States.

Using these experiences and others he has gained as a senior vice president of 天涯社区 and the director of the 天涯社区 Hospital, President Ishibashi is prepared to lead 天涯社区 through uncharted territory as the world continues to grapple with the unprecedented COVID-19 pandemic.

“天涯社区 has an important role pulling together its knowledge and abilities to play its part contributing to the development of a new sustainable society in a world living with and beyond the coronavirus,” stated President Ishibashi.

天涯社区 looks forward to the beginning of a new era under the leadership and guidance of President Ishibashi as it continues its leap into the next.